Table 4

Summary of results for patient-reported outcome measures (n=42)

Within-group change*
Adjusted immediate treatment effect†
Mean (95% CI)
P value‡
HOOS scores
 MoveTrain (n=22)66.6±14.984.7±13.518.1±12.9−2.75 (−8.66 to 3.16)0.35
 Standard (n=20)70.3±12.089.3±8.719.0±9.6
 MoveTrain (n=22)63.2±16.678.0±14.115.0±13.2−5.55 (−13.10 to 1.99)0.14
 Standard (n=20)68.8±15.586.3±13.517.5±16.2
 MoveTrain (n=22)79.5±15.092.0±11.212.5±11.0−2.20 (−6.51 to 2.11)0.32A
 Standard (n=20)83.4±14.795.7±6.212.4±11.8
 MoveTrain (n=22)58.5±20.083.0±16.424.4±18.1−3.69 (−11.74 to 4.36)0.36
 Standard (n=20)69.1±17.690.6±11.221.6±15.6
 MoveTrain (n=22)55.1±14.868.2±16.813.1±13.8−6.60 (−15.32 to 2.13)0.13
 Standard (n=20)52.2±15.273.1±15.320.9±16.6
PSFS, mean of up to five activities
 MoveTrain (n=22)5.8±1.97.5±2.21.7±1.7−0.09 (−1.20 to 1.02)0.87
 Standard (n=20)5.3±1.57.2±2.21.8±1.8
PROMIS T-scores**
PROMIS mobility

 MoveTrain (n=22)50.0±5.753.5±6.13.5±4.8−2.05 (−5.11 to 1.01)0.18
 Standard (n=20)47.9±6.254.3±5.96.4±5.8
PROMIS pain interference
 MoveTrain (n=22)53.6±5.046.8±7.8−6.8±6.3−0.51 (−4.31 to 3.29)0.79††
 Standard (n=20)54.6±4.348.1±6.7−6.5±6.6
PROMIS pain behaviour
 MoveTrain (n=22)55.1±3.246.6±9.0−8.4±7.5−0.47 (−5.24 to 4.30)0.85††
 Standard (n=20)55.2±2.747.3±8.4−7.9±8.5
PROMIS global physical health
 MoveTrain (n=22)49.7±6.156.1±7.46.4±5.40.11 (−3.07 to 3.29)0.95††
 Standard (n=20)49.9±5.756.2±6.46.2±5.7
PROMIS global mental health
 MoveTrain (n=22)52.3±9.453.8±11.21.5±5.6−1.82 (−5.47 to 1.83)0.32
 Standard (n=20)55.5±7.958.7±8.53.2±5.7
Pain numeric rating scales
Pain (average)‡‡
 MoveTrain (n=22)4.1±2.01.3±1.5−2.9±1.50.21 (−0.96 to 1.38)0.73§§
 Standard (n=20)3.5±1.51.0±1.4−2.5±1.9
Pain (worst)‡‡
 MoveTrain (n=22)5.6±2.02.0±1.7−3.7±1.80.36 (−0.74 to 1.46)0.52§§
 Standard (n=20)5.8±1.91.9±2.2−3.9±3.0
  • *Change is calculated by subtracting the pretest value from the post-test value.

  • †The adjusted treatment effect from least squares means is calculated by subtracting the MoveTrain minus Standard at post-test and assesses the between-group difference in post-test values after adjusting for pretest.

  • ‡Unless otherwise indicated, p value by analysis of covariance using a generalised linear model.

  • §Patient-reported outcome measures with 100=no disability.

  • ¶Patient Specific Functional Scale (PSFS) assesses the level of difficulty performing up to five activities due to hip pain or symptoms. 0=unable to perform activity; 10=able to perform activity at preinjury level.

  • **PROMIS T-scores for the measures included in this study range from 20 to 80 and have a mean score of 50 and SD of 10, using the US general population as the reference. A higher score represents more of the concept being measured. Minimally important differences (MIDs) have not been established for those with HRGP. More information regarding PROMIS score interpretation may be found at the following website:

  • ††P value by non-parametric analysis of covariance.

  • ‡‡Pain rated by patients using a verbal numerical pain rating scale. 0=no pain; 10=worst pain imaginable.

  • §§P value by analysis of covariance using multinomial generalised estimating equations with a cumulative logit.

  • HOOS, Hip Disability and Osteoarthritis Outcome Score; HOOSADL, function in activities of daily living; HOOSQOL, quality of life; HOOSSport, function in sports and recreation; HRGP, hip-related groin pain; MoveTrain, movement pattern training group; PROMIS, Patient-Reported Outcomes Measurement Information System.